- Home
- SB vs CRMD Comparison
SB vs CRMD Comparison
Compare SB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SB
- CRMD
- Stock Information
- Founded
- SB 2007
- CRMD 2006
- Country
- SB Monaco
- CRMD United States
- Employees
- SB N/A
- CRMD N/A
- Industry
- SB Marine Transportation
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- SB Consumer Discretionary
- CRMD Health Care
- Exchange
- SB Nasdaq
- CRMD Nasdaq
- Market Cap
- SB 395.3M
- CRMD 464.7M
- IPO Year
- SB 2008
- CRMD 2010
- Fundamental
- Price
- SB $3.42
- CRMD $11.66
- Analyst Decision
- SB Strong Buy
- CRMD Strong Buy
- Analyst Count
- SB 1
- CRMD 6
- Target Price
- SB $6.00
- CRMD $15.00
- AVG Volume (30 Days)
- SB 389.4K
- CRMD 2.2M
- Earning Date
- SB 05-20-2025
- CRMD 05-06-2025
- Dividend Yield
- SB 5.87%
- CRMD N/A
- EPS Growth
- SB 36.11
- CRMD N/A
- EPS
- SB 0.83
- CRMD 0.28
- Revenue
- SB $307,633,000.00
- CRMD $82,553,827.00
- Revenue This Year
- SB N/A
- CRMD $207.65
- Revenue Next Year
- SB $14.32
- CRMD $50.13
- P/E Ratio
- SB $4.12
- CRMD $42.08
- Revenue Growth
- SB 8.17
- CRMD N/A
- 52 Week Low
- SB $3.02
- CRMD $3.61
- 52 Week High
- SB $6.33
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- SB 49.46
- CRMD 71.85
- Support Level
- SB $3.33
- CRMD $8.72
- Resistance Level
- SB $3.53
- CRMD $9.82
- Average True Range (ATR)
- SB 0.09
- CRMD 0.67
- MACD
- SB 0.02
- CRMD 0.40
- Stochastic Oscillator
- SB 67.65
- CRMD 84.78
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.